641 related articles for article (PubMed ID: 3138276)
1. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
2. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
3. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency.
Adams JM; Taylor AE; Schoenfeld DA; Crowley WF; Hall JE
J Clin Endocrinol Metab; 1994 Sep; 79(3):858-64. PubMed ID: 7521353
[TBL] [Abstract][Full Text] [Related]
4. The effects of prolonged opioidergic blockade on LH pulsatile secretion during the menstrual cycle.
Rossmanith WG; Wirth U; Sterzik K; Yen SS
J Endocrinol Invest; 1989 Apr; 12(4):245-52. PubMed ID: 2745936
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
6. Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women.
Taylor AE; Whitney H; Hall JE; Martin K; Crowley WF
J Clin Endocrinol Metab; 1995 May; 80(5):1541-7. PubMed ID: 7744998
[TBL] [Abstract][Full Text] [Related]
7. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
9. Progesterone effects on gonadotropin release in women pretreated with estradiol.
Chang RJ; Jaffe RB
J Clin Endocrinol Metab; 1978 Jul; 47(1):119-25. PubMed ID: 122395
[TBL] [Abstract][Full Text] [Related]
10. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
11. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
[TBL] [Abstract][Full Text] [Related]
12. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
13. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
14. Onset and characteristics of the midcycle surge in bioactive and immunoactive luteinizing hormone secretion in normal women: influence of physiological variations in periovulatory ovarian steroid hormone secretion.
Fritz MA; McLachlan RI; Cohen NL; Dahl KD; Bremner WJ; Soules MR
J Clin Endocrinol Metab; 1992 Aug; 75(2):489-93. PubMed ID: 1639949
[TBL] [Abstract][Full Text] [Related]
15. Opiatergic inhibition of pulsatile luteinizing hormone release during the menstrual cycle of rhesus macaques.
Orstead KM; Hess DL; Spies HG
Proc Soc Exp Biol Med; 1987 Mar; 184(3):312-9. PubMed ID: 3823109
[TBL] [Abstract][Full Text] [Related]
16. Induction of midcycle gonadotropin surge by ovarian steroids in women: a critical evaluation.
Liu JH; Yen SS
J Clin Endocrinol Metab; 1983 Oct; 57(4):797-802. PubMed ID: 6411754
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
Hall JE; Schoenfeld DA; Martin KA; Crowley WF
J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle.
Filicori M; Flamigni C; Campaniello E; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A; Valdiserri A
Am J Physiol; 1989 Dec; 257(6 Pt 1):E930-6. PubMed ID: 2514600
[TBL] [Abstract][Full Text] [Related]
19. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
Gindoff PR; Ferin M
Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
